Followers | 27 |
Posts | 3592 |
Boards Moderated | 0 |
Alias Born | 08/16/2013 |
Saturday, February 18, 2017 11:22:43 AM
OTC rules are simple. I think decision for uplisting last year was more driven by lenders hope for bigger attention and funding than by Koos itself.
They would be punk'd if this goes back to Pink Sheet.
Don't really care about it, but one of Koos big lenders is lawyer and the better ones of them don't like to be played that way.
Last what Koos needs is a new lawsuit at RGBP after Starcity killed BMSN then they forced him to raise the A/S after they won their lawsuit.
Currently it seems we reached point of maximum capitulation here.
That's sad. But good news is that's also the point of maximum financial opportunity.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM